24/7 Customer Support
The closed-loop neurostimulation market is estimated at USD 1.2 billion in 2025 and is projected to reach USD 6.0 billion by 2035, growing at a CAGR of 17.5% over the forecast period 2026–2035.
The targeted protein degradation market is estimated at USD 690.8 million in 2025 and is projected to reach USD 5,004.9 million by 2035, growing at a CAGR of 21.9% over the forecast period 2026–2035.
The bispecific antibodies market is estimated at USD 14.4 billion in 2025 and is projected to reach USD 55.9 billion by 2035, growing at a CAGR of 14.7% over the forecast period 2026–2035.
The global oral GLP-1 drugs market is estimated at USD 6.5 billion in 2025 and is projected to reach USD 32.1 billion by 2035, growing at a CAGR of 24.8% over the forecast period 2025–2035.
Global antibody-drug conjugate (ADC) market size was valued at USD 14.23 billion in 2025 and is projected to hit the market valuation of USD 45.39 billion by 2035 at a CAGR of 12.30% during the forecast period 2026–2035.
Injectable peptides drugs market size was valued at USD 49.10 billion in 2025 and is projected to hit the market valuation of USD 120.57 billion by 2035 at a CAGR of 9.40% during the forecast period 2026–2035.
Thrombus aspiration catheter market size was valued at USD 2.25 billion in 2025 and is projected to hit the market valuation of USD 4.86 billion by 2035 at a CAGR of 8% during the forecast period 2026–2035.
Global micro fulfillment market size was valued at USD 24.20 million in 2025 and is projected to hit the market valuation of USD 45.32 million by 2035 at a CAGR of 6.95% during the forecast period 2026–2035.
Global ocular hypertension market size was valued at USD 4.28 billion in 2025 and is projected to hit the market valuation of USD 9.43 billion by 2035 at a CAGR of 8.22% during the forecast period 2026–2035.
U.S. targeted DNA-RNA sequencing market size was valued at USD 4.92 billion in 2025 and is projected to hit the market valuation of USD 28.54 billion by 2035 at a CAGR of 19.22% during the forecast period 2026–2035.
We use Cookies×
to improve your experience.